ImmuCell Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 6,007 5,390 5,111 4,386
Cost of Revenue 2,947 2,336 2,297 2,084
Gross Profit 3,061 3,054 2,814 2,302
Operating Expenses
Research and Development 1,154 918 1,720 1,493
Sales, General and Admin. 1,926 1,892 1,726 1,500
Non-Recurring Items - - - -
Other - - - -
Operating Income (20) 245 (633) (690)
Income From Continuing Operations
Add'l Income/Expense Items 225 (53) (64) 7
Earnings Before Interest and Tax 205 192 (697) (683)
Interest Expense - - - -
Earnings Before Tax 205 192 (697) (683)
Income Tax 88 103 (287) (299)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 117 90 (410) (385)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 117 90 (410) (385)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 117 90 (410) (385)